Ohio announced Monday that it plans to put to death a prisoner next month with a two-drug cocktail that has never before been tried by any state for an execution.
On Nov. 14, the state plans to use a lethal combination of Midazolam, a sedative, and Hydromorphone, a painkiller, to execute Ronald Phillips, 40, who was sentenced to death 20 years ago for the rape and murder of 3-year-old Sheila Marie Evans.
Ohio’s decision arrives on the heels of an execution that took place in Florida on Oct. 15, where the Sunshine State also used an untried procedure — a three-drug cocktail also including Midazolam — to comply with a death sentence. The execution lasted 14 minutes, or twice what is normally expected with the previous drug of choice.
Ohio, like Florida and Texas, is one of a growing number of death-penalty states scrambling to replace the chemicals it normally relies on to carry out executions. Missouri also planned to use an untested drug — Propofol, an anesthetic that gained notoriety for contributing to Michael Jackson’s death — for an execution this month, but the governor prohibited its use, citing concerns it could inflict an unnecessary amount of pain.
“Ohio reviewed all available information from other states, and considered all available options,” Ricky Seyfang, a spokeswoman for the state’s Department of Rehabilitation and Correction, told National Journal earlier this month. “The combination of Midazolam and Hydromorphone has already been part of Ohio’s execution policy since November 2009, when those two drugs were identified for intramuscular injection, as a backup to the intravenous injection.” Seyfang did not provide further detail about how the drugs were selected.
Ohio has seen a flurry of changes to its lethal-injection protocol in recent years. Until 2009, the state relied on a three-drug combination that was then standard across most states. In December of that year, Ohio became the first state to adopt a single, lethal dose of sodium thiopental, before again changing its procedure in 2011 to allow for only Pentobarbital, a drug commonly used to euthanize pets, to do the trick. Its one-drug use of Pentobarbital was also a first.
But Danish drug manufacturer Lundbeck, buckling under public pressure in the capital-punishment-free European Union, halted sales of Pentobarbital to the states, and Ohio exhausted its supply of Pentobarbital in September. The state then determined it would consult compounding pharmacies — where prescription drugs are individually crafted to fit a person’s medical needs — to secure its Pentobarbital, but updated its execution policy to allow for a backup cocktail — Midazolam and Hydromorphone — in the event Pentobarbital was unavailable.
Compounding pharmacies are lightly regulated and don’t want to be publicly identified as places that make drugs used for executions, and it appears Ohio had little luck finding any willing to supply Pentobarbital. Missouri is now also attempting to secure Pentobarbital from compounding pharmacies.
Whether Ohio forges ahead with its untested cocktail, like Florida, or succumbs to public pressure, like Missouri, remains to be seen. But barring an unlikely spate of execution innovation within the medical community, the routes states can walk to fulfill their death sentences are becoming increasingly narrow.
What We're Following See More »
Foreign Policy takes a look at the future of mining the estimated "100,000 near-Earth objects—including asteroids and comets—in the neighborhood of our planet. Some of these NEOs, as they’re called, are small. Others are substantial and potentially packed full of water and various important minerals, such as nickel, cobalt, and iron. One day, advocates believe, those objects will be tapped by variations on the equipment used in the coal mines of Kentucky or in the diamond mines of Africa. And for immense gain: According to industry experts, the contents of a single asteroid could be worth trillions of dollars." But the technology to get us there is only the first step. Experts say "a multinational body might emerge" to manage rights to NEOs, as well as a body of law, including an international court.
Not to be outdone by Jeffrey Goldberg's recent piece in The Atlantic about President Obama's foreign policy, the New York Times Magazine checks in with a longread on the president's economic legacy. In it, Obama is cognizant that the economic reality--73 straight months of growth--isn't matched by public perceptions. Some of that, he says, is due to a constant drumbeat from the right that "that denies any progress." But he also accepts some blame himself. “I mean, the truth of the matter is that if we had been able to more effectively communicate all the steps we had taken to the swing voter,” he said, “then we might have maintained a majority in the House or the Senate.”
Ronald Reagan's children and political allies took to the media and Twitter this week to chide funnyman Will Ferrell for his plans to play a dementia-addled Reagan in his second term in a new comedy entitled Reagan. In an open letter, Reagan's daughter Patti Davis tells Ferrell, who's also a producer on the movie, “Perhaps for your comedy you would like to visit some dementia facilities. I have—I didn’t find anything comedic there, and my hope would be that if you’re a decent human being, you wouldn’t either.” Michael Reagan, the president's son, tweeted, "What an Outrag....Alzheimers is not joke...It kills..You should be ashamed all of you." And former Rep. Joe Walsh called it an example of "Hollywood taking a shot at conservatives again."
In a sign that she’s ready to put a longer-than-expected primary battle behind her, former Secretary of State Hillary Clinton (D) is no longer going on the air in upcoming primary states. “Team Clinton hasn’t spent a single cent in … California, Indiana, Kentucky, Oregon and West Virginia, while” Sen. Bernie Sanders’ (I-VT) “campaign has spent a little more than $1 million in those same states.” Meanwhile, Sen. Jeff Merkley (D-OR), Sanders’ "lone backer in the Senate, said the candidate should end his presidential campaign if he’s losing to Hillary Clinton after the primary season concludes in June, breaking sharply with the candidate who is vowing to take his insurgent bid to the party convention in Philadelphia.”
The team behind the bestselling "Clinton Cash"—author Peter Schweizer and Breitbart's Stephen Bannon—is turning the book into a movie that will have its U.S. premiere just before the Democratic National Convention this summer. The film will get its global debut "next month in Cannes, France, during the Cannes Film Festival. (The movie is not a part of the festival, but will be shown at a screening arranged for distributors)." Bloomberg has a trailer up, pointing out that it's "less Ken Burns than Jerry Bruckheimer, featuring blood-drenched money, radical madrassas, and ominous footage of the Clintons."